Ms Cynthia Kuehnle Macisaac, | |
1851 Silver Eagle Cir, Leadville, CO 80461-9757 | |
(970) 406-8020 | |
Not Available |
Full Name | Ms Cynthia Kuehnle Macisaac |
---|---|
Gender | Female |
Speciality | Occupational Therapist - Pediatrics |
Location | 1851 Silver Eagle Cir, Leadville, Colorado |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1992203681 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | OT.0001785 (Colorado) | Secondary |
225XP0200X | Occupational Therapist - Pediatrics | 0001785 (Colorado) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Cynthia Kuehnle Macisaac, 1851 Silver Eagle Cir, Leadville, CO 80461-9757 Ph: (719) 486-1689 | Ms Cynthia Kuehnle Macisaac, 1851 Silver Eagle Cir, Leadville, CO 80461-9757 Ph: (970) 406-8020 |
News Archive
Could blocking a testosterone receptor lead to a new way to treat an aggressive form of breast cancer? That's a question researchers at Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) are exploring. Preliminary results of a Mayo Clinic - TGen collaborative study shows the testosterone receptor may be a potential target to attack in treating triple negative breast cancer (TNBC).
Scientists at Jefferson's Kimmel Cancer Center in Philadelphia have made an extraordinary advance in the understanding of the function of a gene previously shown to be part of an 11-gene "signature" that can predict which tumors will be aggressive and likely to spread.
Teva Pharmaceutical Industries Ltd. today announced that its subsidiary, Teva Pharmaceuticals USA, Inc., has signed an agreement with Novartis to settle patent litigation involving Teva's U.S. generic version of Novartis' Famvir® (famciclovir) 125 mg, 250 mg and 500 mg tablets including all claims for patent infringement and damages. Teva launched its generic famciclovir tablets in the U.S. in September 2007.
Hospital acquired infections are the focus for the 3rd International Day for Fighting Infection, being marked on St. George's Day, as experts meet to look at the evolution of infection control in hospitals.
› Verified 8 days ago